AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹1.30 Cr | ₹-5.88 Cr | ₹0.65 Cr | ₹-1.97 Cr | ₹-2.64 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹1.30 Cr |
| Mar2025 | ₹-5.88 Cr |
| Mar2024 | ₹0.65 Cr |
| Mar2023 | ₹-1.97 Cr |
| Mar2022 | ₹-2.64 Cr |
How is Net Cash Inflow / Outflow of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.30 Cr | Positive | |
| Mar2025 | ₹-5.88 Cr | Negative | |
| Mar2024 | ₹0.65 Cr | Positive | |
| Mar2023 | ₹-1.97 Cr | Negative | |
| Mar2022 | ₹-2.64 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹238.1 Cr | 0.8% | -6.1% | -13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 0.8% |
-6.1% |
-13.5% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses